Epidrugs: targeting epigenetic marks in cancer treatment

CL Miranda Furtado, MC Dos Santos Luciano… - Epigenetics, 2019 - Taylor & Francis
Growing evidence suggests that aberrant epigenetic regulation of gene function is strongly
related to the genesis of cancer. Unlike genetic mutations, the ability to reprogram the …

Polyphenol effects on cholesterol metabolism via bile acid biosynthesis, CYP7A1: a review

KF Chambers, PE Day, HT Aboufarrag, PA Kroon - Nutrients, 2019 - mdpi.com
Atherosclerosis, the main contributor to coronary heart disease, is characterised by an
accumulation of lipids such as cholesterol in the arterial wall. Reverse cholesterol transport …

[HTML][HTML] Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents

M Hashemi, MSA Mirdamadi, Y Talebi… - Pharmacological …, 2023 - Elsevier
The field of non-coding RNA (ncRNA) has made significant progress in understanding the
pathogenesis of diseases and has broadened our knowledge towards their targeting …

Small in size, but large in action: microRNAs as potential modulators of PTEN in breast and lung cancers

AJ Abadi, A Zarrabi, MH Gholami, S Mirzaei… - Biomolecules, 2021 - mdpi.com
MicroRNAs (miRNAs) are well-known regulators of biological mechanisms with a small size
of 19–24 nucleotides and a single-stranded structure. miRNA dysregulation occurs in cancer …

Silibinin to improve cancer therapeutic, as an apoptotic inducer, autophagy modulator, cell cycle inhibitor, and microRNAs regulator

Z Jahanafrooz, N Motamed, B Rinner, A Mokhtarzadeh… - Life sciences, 2018 - Elsevier
Silibinin is a natural plant polyphenol with high antioxidant and anticancer properties, which
causes broad-spectrum efficacy against cancer, including cell cycle arrest and apoptosis in …

Polyphenols as promising drugs against main breast cancer signatures

M Losada-Echeberría, M Herranz-López, V Micol… - Antioxidants, 2017 - mdpi.com
Breast cancer is one of the most common neoplasms worldwide, and in spite of clinical and
pharmacological advances, it is still a clinical problem, causing morbidity and mortality. On …

Downregulation of miR-21 as a promising strategy to overcome drug resistance in cancer

T Akhtarkhavari, AR Bahrami, MM Matin - European Journal of …, 2022 - Elsevier
Despite tremendous achievements in the field of targeted cancer therapy, chemotherapy is
still the main treatment option, which is challenged by acquired drug resistance. Various …

Nanobiomaterials in drug delivery: from science to applications

N Kazemi, B Bakhshandeh, Z Dehghani… - Polymer Bulletin, 2024 - Springer
Recently, technologies in designing novel drug delivery strategies have evolved to
overcome challenges like biological barriers. Nanobiomaterials have shown significant …

Anti-oxidants as chemopreventive agents in prostate cancer: A gap between preclinical and clinical studies

M Mohsenzadegan, F Seif… - Recent patents on …, 2018 - ingentaconnect.com
Background: Tumor cells may be expressed as a result of oxidative stress. The extent of
oxidative stress correlates with the aggressive and metastatic potency of cancer. Objective …

A smart ATP-responsive chemotherapy drug-free delivery system using a DNA nanostructure for synergistic treatment of breast cancer in vitro and in vivo

K Abnous, NM Danesh, M Ramezani… - Journal of Drug …, 2020 - Taylor & Francis
This study demonstrated a chemotherapy drug-free delivery system for breast cancer
treatment based on a simple DNA nanostructure composed of sequence 1 containing ATP …